[Eosinophils and related diseases].
Di
Yu-wei
YW
Liu
Yan-hui
YH
Zhuang
Heng-guo
HG
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000473:pathology; D001549:Benzamides; D002454:Cell Differentiation; D002465:Cell Movement; D002470:Cell Survival; D004802:Eosinophilia / Q000139:chemically induced / Q000473:pathology*; D004804:Eosinophils / Q000166:cytology* / Q000502:physiology; D006373:Helminthiasis / Q000473:pathology; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000188:drug therapy / Q000473:pathology*; D006967:Hypersensitivity / Q000473:pathology*; D000068877:Imatinib Mesylate; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate